Simplex Trading’s CorMedix CRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $458K | Buy |
67,500
+28,000
| +71% | +$207K | ﹤0.01% | 3370 |
|
|
2025
Q4 | $459K | Sell |
39,500
-66,400
| -63% | -$734K | ﹤0.01% | 3385 |
|
|
2025
Q3 | $1.23M | Buy |
105,900
+82,300
| +349% | +$995K | ﹤0.01% | 2832 |
|
|
2025
Q2 | $290K | Sell |
23,600
-47,300
| -67% | -$522K | ﹤0.01% | 4102 |
|
|
2025
Q1 | $436K | Buy |
70,900
+34,200
| +93% | +$354K | ﹤0.01% | 3527 |
|
|
2024
Q4 | $297K | Buy |
36,700
+17,200
| +88% | +$172K | ﹤0.01% | 4072 |
|
|
2024
Q3 | $157K | Sell |
19,500
-40,700
| -68% | -$220K | ﹤0.01% | 4759 |
|
|
2024
Q2 | $260K | Sell |
60,200
-25,800
| -30% | -$131K | ﹤0.01% | 4383 |
|
|
2024
Q1 | $364K | Buy |
86,000
+15,700
| +22% | +$54.4K | ﹤0.01% | 4179 |
|
|
2023
Q4 | $264K | Buy |
70,300
+37,900
| +117% | +$130K | ﹤0.01% | 4371 |
|
|
2023
Q3 | $119K | Sell |
32,400
-46,600
| -59% | -$185K | ﹤0.01% | 4911 |
|
|
2023
Q2 | $313K | Buy |
79,000
+58,300
| +282% | +$288K | ﹤0.01% | 3787 |
|
|
2023
Q1 | $85K | Sell |
20,700
-100
| -0.5% | -$409 | ﹤0.01% | 5327 |
|
|
2022
Q4 | $87K | Sell |
20,800
-18,100
| -47% | -$64K | ﹤0.01% | 5243 |
|
|
2022
Q3 | $110K | Buy |
38,900
+28,700
| +281% | +$119K | ﹤0.01% | 5382 |
|
|
2022
Q2 | $41K | Sell |
10,200
-1,200
| -11% | -$4.46K | ﹤0.01% | 6732 |
|
|
2022
Q1 | $62K | Buy |
11,400
+2,300
| +25% | +$10.5K | ﹤0.01% | 6830 |
|
|
2021
Q4 | $41K | Buy |
9,100
+3,500
| +63% | +$17.4K | ﹤0.01% | 7492 |
|
|
2021
Q3 | $39K | Hold |
5,600
| – | – | ﹤0.01% | 7811 |
|
|
2021
Q2 | $38K | Buy |
5,600
+5,403
| +2,743% | +$43K | ﹤0.01% | 7964 |
|
|
2021
Q1 | $196K | Sell |
197
-27
| -12% | -$284 | ﹤0.01% | 4772 |
|
|
2020
Q4 | $166K | Buy |
224
+90
| +67% | +$612 | ﹤0.01% | 4851 |
|
|
2020
Q3 | $80K | Sell |
134
-155
| -54% | -$778 | ﹤0.01% | 5132 |
|
|
2020
Q2 | $182K | Buy |
289
+124
| +75% | +$574 | ﹤0.01% | 4100 |
|
|
2020
Q1 | $59K | Sell |
165
-57
| -26% | -$322 | ﹤0.01% | 4959 |
|
|
2019
Q4 | $161K | Buy |
222
+168
| +311% | +$1.03K | ﹤0.01% | 3988 |
|
|
2019
Q3 | $34K | Sell |
54
-152
| -74% | -$1.28K | ﹤0.01% | 5364 |
|
|
2019
Q2 | $184K | Buy |
206
+199
| +2,843% | +$1.56K | ﹤0.01% | 3543 |
|
|
2019
Q1 | $6K | Buy |
+7
| New | +$63 | ﹤0.01% | 6399 |
|
|
2018
Q4 | – | Sell |
-8
| Closed | -$3K | – | 7103 |
|
|
2018
Q3 | $3K | Sell |
8
-2
| -20% | -$5 | ﹤0.01% | 6940 |
|
|
2018
Q2 | $1K | Sell |
10
-14
| -58% | -$16 | ﹤0.01% | 7131 |
|
|
2018
Q1 | $27K | Buy |
24
+19
| +380% | +$38 | ﹤0.01% | 3045 |
|
|
2017
Q4 | $11K | Sell |
5
-6
| -55% | -$17 | ﹤0.01% | 3792 |
|
|
2017
Q3 | $24K | Buy |
+11
| New | +$23 | ﹤0.01% | 2976 |
|
|
2017
Q2 | – | Sell |
-51
| Closed | -$148K | – | 6188 |
|
|
2017
Q1 | $148K | Sell |
51
-6
| -11% | -$57 | 0.01% | 1437 |
|
|
2016
Q4 | $173K | Buy |
57
+49
| +613% | +$496 | 0.01% | 1147 |
|
|
2016
Q3 | $28K | Hold |
8
| – | – | ﹤0.01% | 2624 |
|
|
2016
Q2 | $30K | Sell |
8
-20
| -71% | -$305 | ﹤0.01% | 2521 |
|
|
2016
Q1 | $64K | Sell |
28
-30
| -52% | -$291 | 0.01% | 1741 |
|
|
2015
Q4 | $105K | Sell |
58
-2
| -3% | -$23 | 0.01% | 1307 |
|
|
2015
Q3 | $170K | Sell |
60
-29
| -33% | -$447 | 0.01% | 1018 |
|
|
2015
Q2 | $262K | Buy |
+89
| New | +$3.05K | 0.02% | 663 |
|
Other funds holding CRMD
DTC
VCM
RA
OAM
VPM
Simplex Trading's CRMD Position: Q4 2025 in Review
Simplex Trading sold out of CorMedix (CRMD) in Q4 2025, closing a stake of 32,232 shares — an estimated $356K sold.
Simplex Trading first reported a position in CRMD in Q1 2015 and held it in 33 quarters. The position peaked at $1.79M in Q3 2024. 198 funds tracked by Wall St. Rank hold CRMD as of Q4 2025.
- Simplex Trading reported no remaining CorMedix position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 32,232 CorMedix shares in Q4 2025, an estimated $356K.
- Simplex Trading first reported a position in CorMedix in Q1 2015 and held it in 33 quarters.
- Simplex Trading's CorMedix position peaked at $1.79M in Q3 2024.
- 198 funds tracked by Wall St. Rank held CorMedix as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.